LifeSensors, Inc is pleased to announce it has been granted CLIA certification in light of the COVID-19 pandemic. With this new certification, LifeSensors will be able to aid with the heavy influx of COVID-19 test processing throughout the country. Armed with high-performance testing technologies, as well as highly trained scientific professionals, the Malvern biotechnology corporation will be able to receive samples from strained and overloaded testing facilities and hospitals.
As assistance with mass COVID-19 testing begins, LifeSensors, Inc continues its own research and development efforts within the infectious disease sector. Recognizing the dire need for improved testing, LifeSensors is not only focusing its attention on assisting other laboratories but in creating new diagnostics for the ongoing pandemic. As COVID-19 testing is shifting towards serological testing, LifeSensors is positioned to be a key player in this role on a global scale.
For any questions or interest, please reach out to Myra Zerr at email@example.com/lifesensors or at (610) 644-8845 ext 339.
If you feel that a HIPPA violation has occurred, please visit https://www.hhs.gov/hipaa/filing-a-complaint/index.html for further guidance.